Trial intelligence / Profile preview

Phase 1 Study of DS-6051b in Japanese Subjects with Advanced Solid Malignant Tumors Harboring ROS1 or NTRK Fusion

jRCT2080223057Phase 1Completed

Sponsor

Daiichi Sankyo Co., Ltd.

Start

Dec 2015

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1